Xuben Hou
Impact in
-
- Computational Drug Discovery Methods
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Histone Deacetylase Inhibitors Research 23
- Protein Tyrosine Phosphatases 14
- Cell death mechanisms and regulation 12
- Protein Degradation and Inhibitors 4
-
- Computational Drug Discovery Methods 14
- Co-authors
- Hao Fang (66 shared papers)Xinying Yang (25 shared papers)Yingkai Zhang (10 shared papers)Jintong Du (15 shared papers)Liang Tao (8 shared papers)Cai Zhang (1 shared paper)Nan Lü (1 shared paper)Zhigang Tian (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry (12 papers)European Journal of Medicinal Chemistry (10 papers)Journal of Chemical Information and Modeling (7 papers)Journal of Medicinal Chemistry (7 papers)Current Medicinal Chemistry (5 papers)
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Xuben Hou
86 papers receiving 2.1k citations
Xuben Hou's Hit Papers
Peers
Comparison fields: 5 of 91
- Computational Theory and Mathematics 297
- Geriatrics and Gerontology 58
- Molecular Biology 1k
- Organic Chemistry 299
- Hepatology 37
Countries citing papers authored by Xuben Hou
This map shows the geographic impact of Xuben Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuben Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuben Hou more than expected).
Fields of papers citing papers by Xuben Hou
This network shows the impact of papers produced by Xuben Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuben Hou. The network helps show where Xuben Hou may publish in the future.
Co-authors
The 25 scholars most cited alongside Xuben Hou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 314 | |
| 2 | Targeting histone deacetylases for cancer therapy: Trends and challenges Hit paper breakdown → | 2023 | 149 |
| 3 | 2012 | 121 | |
| 4 | 2020 | 101 | |
| 5 | 2019 | 96 | |
| 6 | 2016 | 90 | |
| 7 | 2021 | 71 | |
| 8 | 2013 | 61 | |
| 9 | 2020 | 50 | |
| 10 | 2012 | 46 | |
| 11 | 2015 | 42 | |
| 12 | 2021 | 42 | |
| 13 | 2015 | 40 | |
| 14 | 2017 | 40 | |
| 15 | 2014 | 35 | |
| 16 | 2022 | 30 | |
| 17 | 2021 | 29 | |
| 18 | 2014 | 28 | |
| 19 | 2015 | 28 | |
| 20 | 2015 | 28 |
About Xuben Hou
Xuben Hou is a scholar working on Molecular Biology, Computational Theory and Mathematics, Organic Chemistry, Spectroscopy and Geriatrics and Gerontology, having authored 92 papers that have together received 2.1k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (23 papers), Computational Drug Discovery Methods (14 papers), Protein Tyrosine Phosphatases (14 papers), Synthesis and biological activity (12 papers), Cell death mechanisms and regulation (12 papers), Protein Degradation and Inhibitors (4 papers), Molecular Sensors and Ion Detection (4 papers) and Antifungal resistance and susceptibility (3 papers). The work is most often cited by research in Computational Theory and Mathematics (297 citations), Geriatrics and Gerontology (58 citations), Molecular Biology (1k citations), Organic Chemistry (299 citations) and Hepatology (37 citations). Xuben Hou has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Hao Fang, Xinying Yang, Yingkai Zhang, Jintong Du, Liang Tao, Cai Zhang, Nan Lü, Zhigang Tian, Xin Yu and Tao Li. Their work appears in journals such as Bioorganic & Medicinal Chemistry, European Journal of Medicinal Chemistry, Journal of Chemical Information and Modeling, Journal of Medicinal Chemistry and Current Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.